ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04380	Osteoclast differentiation	7/31	134/7206	1.19106895278e-06
ko04657	IL-17 signaling pathway	6/31	87/7206	1.50416028325e-06
ko04064	NF-kappa B signaling pathway	6/31	96/7206	2.68790571511e-06
ko04668	TNF signaling pathway	6/31	120/7206	9.85562273856e-06
ko05140	Leishmaniasis	5/31	75/7206	1.46842981861e-05
ko04620	Toll-like receptor signaling pathway	5/31	100/7206	5.93955903498e-05
ko05152	Tuberculosis	6/31	187/7206	0.000120825391854
ko05142	Chagas disease (American trypanosomiasis)	5/31	130/7206	0.000206245519859
ko05133	Pertussis	4/31	87/7206	0.000486312469618
ko04621	NOD-like receptor signaling pathway	5/31	157/7206	0.000494957875171
ko05161	Hepatitis B	5/31	173/7206	0.000770690118341
ko04210	Apoptosis	5/31	180/7206	0.000922154863474
ko04624	Toll and Imd signaling pathway	3/31	49/7206	0.0011618463513
ko05166	HTLV-I infection	6/31	292/7206	0.00131379784851
ko05162	Measles	4/31	120/7206	0.00162561324798
ko04660	T cell receptor signaling pathway	4/31	124/7206	0.00183436593591
ko05145	Toxoplasmosis	4/31	126/7206	0.00194544048775
ko04010	MAPK signaling pathway	6/31	321/7206	0.00213393976946
ko05134	Legionellosis	3/31	74/7206	0.003801597831
ko05164	Influenza A	4/31	167/7206	0.00537311390093
ko04662	B cell receptor signaling pathway	3/31	88/7206	0.0061795128163
ko05168	Herpes simplex infection	4/31	182/7206	0.00726863326352
ko00073	Cutin, suberine and wax biosynthesis	1/31	2/7206	0.008586028722
ko05167	Kaposi's sarcoma-associated herpesvirus infection	4/31	191/7206	0.00859589043516
ko04659	Th17 cell differentiation	3/31	106/7206	0.0103123776038
ko04672	Intestinal immune network for IgA production	2/31	37/7206	0.0108628854061
ko05169	Epstein-Barr virus infection	4/31	206/7206	0.0111468396466
ko04623	Cytosolic DNA-sensing pathway	2/31	41/7206	0.0132329641621
ko05144	Malaria	2/31	45/7206	0.0158072153494
ko04630	Jak-STAT signaling pathway	3/31	132/7206	0.0185788128768
ko04933	AGE-RAGE signaling pathway in diabetic complications	3/31	135/7206	0.0197135136824
ko05321	Inflammatory bowel disease (IBD)	2/31	56/7206	0.0238809249142
ko05160	Hepatitis C	3/31	153/7206	0.0273199458666
ko04622	RIG-I-like receptor signaling pathway	2/31	62/7206	0.0288612484337
ko04218	Cellular senescence	3/31	177/7206	0.0395875877751
ko04060	Cytokine-cytokine receptor interaction	3/31	191/7206	0.047848040131
ko05131	Shigellosis	2/31	82/7206	0.0480780190657